WIBF and Refine Technology Collaborate on Vaccines
The Wuhan Institute of Biological Products (WIBF) formed a collaboration with Refine Technology, a US maker of biological manufacturing equipment. WIBF is a division of China National Biological Group, a Sinopharm subsidiary. WIPF and Refine will use Refine’s ATF™ System, a cell retention device, to improve the yield and reduce the cost of vaccine manufacturing. The collaboration will work on a specific novel vaccine, which was not identified. More details.... Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here